Skip to main content

ORIGINAL RESEARCH article

Front. Pediatr.
Sec. Neonatology
Volume 12 - 2024 | doi: 10.3389/fped.2024.1440537
This article is part of the Research Topic Recent Advances in Our Understanding of NEC Pathogenesis, Diagnosis, and Treatment - Volume II View all 5 articles

The effect of Haemoglobin and Blood Transfusion on Preterm Infant Gut Perfusion and Injury

Provisionally accepted
  • 1 Neonatal Unit, Homerton Healthcare NHS Foundation Trust, London, London, United Kingdom
  • 2 University College London Great Ormond Street Institute of Child Health, London, United Kingdom
  • 3 Nottingham Trent University, Nottingham, United Kingdom
  • 4 Imperial College Healthcare NHS Trust and Imperial College London, London, United Kingdom
  • 5 Department of Medical Physics and Biomedical Engineering, Faculty of Engineering Sciences, University College London, London, England, United Kingdom
  • 6 St George's, University of London, London, England, United Kingdom

The final, formatted version of the article will be published soon.

    Introduction: There is significant uncertainty regarding the role that anaemia or red blood cell transfusion (RBCT) plays in the development of gut injury in preterm infants. This study evaluated Near Infrared Spectroscopy (NIRS) together with a range of known biomarkers of gut inflammation to identify their relationship with anaemia and RBCT.Method: A prospective observational study of preterm infants born at <30 weeks gestation was conducted from birth until either 36 weeks post conceptional age or discharge home. Gut perfusion and biomarkers of gut injury were assessed weekly by: 60 minutes NIRS measurements (splanchnic tissue oxygenation index [sTOI] and fractional tissue oxygenation extraction [sFTOE]); stool calprotectin; urine intestinal and liver fatty acid binding proteins (I-FABPs and L-FABPs); and trefoil factor 3 (TFF-3). Exclusion criteria included Fetal Growth Restriction (FGR), and abnormal antenatal Dopplers. Haemoglobin (Hb) levels were measured in parallel with NIRS measurements.NIRS, together with urine and stool biomarkers of gut injury, were evaluated up to 72 hours pre/post RBCT and pre/post measurements compared.Results: Forty-eight infants were studied. Median (range) gestational age was 26 +3 (23 +0 to 29 +6 ) weeks and birthweight 883.5g (460 to 1600). Seven (14.6%) infants developed ≥Bells stage 2 NEC. Infants were in the study for a median of 7.3 (1-13) weeks. There was no significant association between Hb divided into three categories (<80g/l, 80-111.9g/l and ≥120g/l) or continuous values and sTOI, sFTOE or any of the gut injury biomarkers measured (p >0.05). 283 RBCTs were administered; 117 (41.3%) within the first two weeks of life. Pre and post blood transfusion changes in splanchnic NIRS oxygenation, urine and stool gut injury biomarkers were measured in 165, 195 and 175 episodes of RBCT respectively.There was no significant post RBCT changes in splanchnic NIRS or gut injury biomarker levels (p >0.05).Conclusion: There was no association between anaemia or RBCT with NIRS measurements of tissue oxygen saturation and biomarkers of intestinal inflammation or gut injury in preterm infants enrolled in this study. Further studies with standardised methods of examining the relationship between anaemia, RBCT and gut injury are needed.

    Keywords: haemoglobin, Blood Transfusion, preterm infants, Gut perfusion, Gut injury, NEC

    Received: 29 May 2024; Accepted: 28 Oct 2024.

    Copyright: © 2024 Howarth, Mifsud, BANERJEE, Eaton, Leung, Fleming, Morris and Aladangady. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Narendra Aladangady, Neonatal Unit, Homerton Healthcare NHS Foundation Trust, London, London, United Kingdom

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.